
    
      This is a prospective, single-arm, multi-center, observational, post-market registry study.
      The purpose is to evaluate the safety, performance, and effectiveness of the VitaFlowâ„¢
      Transcatheter Aortic Valve System in the real world settings.Patients will be seen at pre and
      post procedure, discharge, 30 days, 1 year and annually up to 5 years.
    
  